Is it just me or did mgmt seem a bit more open about a buy out? NP said if the price is right they will bring it to the shareholders and Dr Kelly mentioned a presentation in April he will be doing in front of big pharmas...why would it matter if big pharmas are there? Plus it sounds like we were approached at least once per NP saying something about not taking into account some valuation after a phase 2....

Maybe it's just me, but they didn't completely shut it down and day "no, our goal is to develop into a major pharmaceutical 10x gilead" as in past calls. Just an observation. Worth what you paid for it.